To investigate the responsiveness of ER and PR in breast cancer cells, we generated a novel construct, p(ERE)2-(PRE)2FLuc, with two double-responsive elements ((ERE)2-(PRE)2) engineered to be directly connected through their auxiliary sequences (Fig. S2). The gene discussed is ESR1; the disease is breast carcinoma.